Search - tctmd.com

Displaying 181 - 200 of 259

Sort: Relevancy | Date

Presentation TCT 2018

Introduction: What Do We Hope to Learn From These Cases?

Presenter: Massimo Napodano, Bernard Prendergast

September 22, 2018

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

Presentation TCT 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno

September 22, 2018

Presentation TCT 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla

September 22, 2018

Presentation TCT 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke

September 22, 2018

Presentation TCT 2018

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb

September 22, 2018

Presentation TCT 2017

Tricuspid Valve-in-Valve and Valve-in-Ring

Presenter: Francesco Maisano, Jason H. Rogers, Paul Sorajja

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

Case Presentation: Valve-in-Valve

Presenter: Mayra Guerrero, John G. Webb, Brian K. Whisenant

October 31, 2017

Presentation TCT 2017

Valve-in-Valve: Patient Selection, Technical Pearls, and Outcomes

Presenter: Mayra Guerrero, John G. Webb, Isaac George

October 31, 2017

Presentation TCT 2017

Korea Presents: A Case of Valve-in-Valve TAVR

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Bon-Kwon Koo

October 31, 2017

Presentation TCT 2017

Serbia Presents: Valve-in-Valve After TAVR Device Degeneration

Presenter: Emmanouil I Skalidis, Milan A. Nedeljkovic

October 31, 2017

Presentation TCT 2017

A Rare Complication of Valve-in-valve TAVR: Dynamic Intracavitary LV Obstruction

Presenter: Wojtek Wojakowski, Edwina C Wing-Lun

October 30, 2017

Presentation TCT 2017

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Presenter: Danny Dvir

October 30, 2017

Presentation TCT 2017

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

Presenter: Vinayak Bapat

October 30, 2017

Presentation TCT 2017

Percutaneous Mitral Valve-in Valve Implantation With SAPIEN 3 Prosthesis Using an Anterograde Transvenous Transseptal Approach

Presenter: Vasilis Babaliaros, Shmuel Banai, Caterina Gandolfo

October 30, 2017

Presentation TCT 2017

Case #4: Trans-septal Mitral ViV With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Mackram F. Eleid

October 30, 2017

Presentation TCT 2017

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Vinayak Bapat

October 30, 2017

Advertisement

Introduction: What Do We Hope to Learn From These Cases?

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Tricuspid Valve-in-Valve and Valve-in-Ring

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Case Presentation: Valve-in-Valve

Valve-in-Valve: Patient Selection, Technical Pearls, and Outcomes

Korea Presents: A Case of Valve-in-Valve TAVR

Serbia Presents: Valve-in-Valve After TAVR Device Degeneration

A Rare Complication of Valve-in-valve TAVR: Dynamic Intracavitary LV Obstruction

How to Optimally Perform Valve-in-Valve Implantation in a Small Surgical Valve (Including Bioprosthetic Valve Fracture) Case Examples

Understanding Surgical Aortic Valve Anatomy: Implications for Valve-in-Valve Therapy

Percutaneous Mitral Valve-in Valve Implantation With SAPIEN 3 Prosthesis Using an Anterograde Transvenous Transseptal Approach

Case #4: Trans-septal Mitral ViV With SAPIEN 3 (With Discussion)

Case #3: Transapical Mitral ViV With Lotus (With Discussion)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content